Mesa Laboratories Inc (MLAB)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands -269,832 -265,669 -270,806 -275,648 -593 -623 4,086 -389 -158 -4,415 -3,256 3,574 8,512 5,126 2,967 1,931 -3,349 -2,825 -1,545 3,433
Revenue (ttm) US$ in thousands 237,747 228,380 223,712 216,187 212,874 213,688 219,272 219,080 222,368 222,777 199,868 184,335 163,420 142,896 138,916 133,937 130,181 127,664 121,340 117,687
Pretax margin -113.50% -116.33% -121.05% -127.50% -0.28% -0.29% 1.86% -0.18% -0.07% -1.98% -1.63% 1.94% 5.21% 3.59% 2.14% 1.44% -2.57% -2.21% -1.27% 2.92%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-269,832K ÷ $237,747K
= -113.50%

Mesa Laboratories Inc's pretax margin has displayed fluctuations over the reported periods. From March 31, 2020, to March 31, 2022, the pretax margin ranged from -1.98% to 5.21%, indicating varying levels of profitability before accounting for taxes. However, the following periods from June 30, 2022, to December 31, 2024, saw a significant decline in the pretax margin, with percentages falling into negative triple digits. This downward trend suggests challenges in generating profits before tax expenses during these periods, potentially indicating financial distress or operational inefficiencies. Further analysis would be needed to understand the underlying reasons behind these drastic shifts in the pretax margin for Mesa Laboratories Inc.